1. Home
  2. BCTX vs GRNQ Comparison

BCTX vs GRNQ Comparison

Compare BCTX & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.50

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.30

Market Cap

23.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCTX
GRNQ
Founded
2014
2013
Country
Canada
Malaysia
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
23.6M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
BCTX
GRNQ
Price
$3.50
$1.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$40.00
N/A
AVG Volume (30 Days)
127.0K
4.7K
Earning Date
06-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,673,997.00
Revenue This Year
N/A
N/A
Revenue Next Year
$380.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.55
52 Week Low
$0.63
$1.04
52 Week High
$14.68
$3.18

Technical Indicators

Market Signals
Indicator
BCTX
GRNQ
Relative Strength Index (RSI) 49.70 42.20
Support Level $2.98 $1.04
Resistance Level $4.51 $1.81
Average True Range (ATR) 0.26 0.12
MACD -0.04 0.01
Stochastic Oscillator 34.62 38.67

Price Performance

Historical Comparison
BCTX
GRNQ

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China, and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust, & wealth management. Its segments include the Service business engaged in the provision of corporate advisory & business solution services; the Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong & Malaysia; & the Digital business segment engaged in the provision of digital platform & trading of digital assets.

Share on Social Networks: